Hall Justin
Insider CIK 1663021 · NBY SVP, General Counsel, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| NBY NovaBay Pharmaceuticals, I | P Buy | 2022-09-14 | 2022-09-16 | 10,000 | $0.15 | $1.5K | 83,172 | SEC↗ |
| NBY NovaBay Pharmaceuticals, I | P Buy | 2021-12-06 | 2021-12-06 | 69,767 | $0.43 | $30.0K | 73,172 | SEC↗ |
| NBY NovaBay Pharmaceuticals, I | A Award deriv | 2020-08-20 | 2020-08-24 | 350,000 | — | $0 | 350,000 | SEC↗ |
| NBY NovaBay Pharmaceuticals, I | X Exercise deriv | 2019-06-10 | 2019-10-28 | 47,500 | — | $0 | 0 | SEC↗ |
| NBY NovaBay Pharmaceuticals, I | S Sale | 2019-06-10 | 2019-10-28 | 47,500 | $3.03 | $143.9K | 3,405 | SEC↗ |
| NBY NovaBay Pharmaceuticals, I | A Award | 2019-06-10 | 2019-10-28 | 47,500 | $2.02 | $96.0K | 50,905 | SEC↗ |
| NBY NovaBay Pharmaceuticals, I | X Exercise deriv | 2019-06-10 | 2019-06-12 | 47,500 | — | $0 | 0 | SEC↗ |
| NBY NovaBay Pharmaceuticals, I | A Award deriv | 2018-05-31 | 2018-06-01 | 190,000 | — | $0 | 345,710 | SEC↗ |
| NBY NovaBay Pharmaceuticals, I | X Exercise deriv | 2017-09-14 | 2017-09-18 | 20,000 | — | $0 | 278,160 | SEC↗ |
| NBY NovaBay Pharmaceuticals, I | A Award deriv | 2017-01-25 | 2017-01-26 | 143,000 | — | $0 | 278,160 | SEC↗ |
| NBY NovaBay Pharmaceuticals, I | A Award deriv | 2016-06-06 | 2016-06-09 | 130,000 | — | $0 | 135,160 | SEC↗ |
| NBY NovaBay Pharmaceuticals, I | A Award deriv | 2016-03-09 | 2016-03-09 | 5,000 | — | $0 | 2,400 | SEC↗ |